Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
54
54 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- MT-4561Phase 21 trial
Tanabe Pharma America, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Non-small Cell Lung Cancer (NSCLC), Esophageal Cancer
- NP137Phase 21 trial
NETRIS Pharma · Endometrial Carcinoma, Cervix Carcinoma
- REGN5668ubletamigPhase 21 trial
Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
- TER-2013Phase 21 trial
Terremoto Biosciences Inc. · Breast Cancer, Endometrial Cancer, Ovarian Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.